Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Price:
10.54 USD
-1.4%
Market Closed
Updated:
May 20, 2024
Phathom Pharmaceuticals Inc
Net Change in Cash
|
Phathom Pharmaceuticals Inc
Net Change in Cash Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
|
Net Change in Cash
$228.4m
|
CAGR 3-Years
73%
|
CAGR 5-Years
204%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Change in Cash
-$1.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Change in Cash
$286m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-23%
|
|
|
Pfizer Inc
NYSE:PFE
|
Net Change in Cash
-$1.4B
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Net Change in Cash
-$4.1B
|
CAGR 3-Years
-111%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Change in Cash
-$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-36%
|
See Also
What is Phathom Pharmaceuticals Inc's Net Change in Cash?
Net Change in Cash
228.4m
USD
228.4m
USD
Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Net Change in Cash amounts to 228.4m USD.
What is Phathom Pharmaceuticals Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
204%
204%
The average annual Net Change in Cash growth rates for Phathom Pharmaceuticals Inc have been 73% over the past three years , 204% over the past five years .
You don't have any saved screeners yet
